SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending heavily following a sharp drop in share price after the company reported disappointing fiscal second-quarter results and cut its full-year guidance. While retail traders are divided on the stock's future, much of the discussion focuses on Michael Burry's public commitment to increasing his position below $100, fueling intense debate between those betting on a long-term turnaround and those viewing the brand as in terminal decline.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla shares are facing downward pressure as investors react to the company's Cybercab event, which many traders characterized as underwhelming due to a lack of livestreaming and deployment details, as well as a newly opened NHTSA inquiry into the vehicle's certification. While some traders are capitalizing on the volatility with aggressive short positions, others are viewing the pullback as a potential buying opportunity, citing the company's autonomous milestones.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending following a significant single-day rally that traders largely attribute to aggressive share buyback activity and heavy options-related gamma positioning. Community sentiment is deeply divided, with bulls pointing to the buybacks and memory demand as reasons to hold, while bears dismiss the price action as a manipulated bubble or "scam" fueled by low volume.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing selling pressure following the announcement of subscription price hikes in the United Kingdom, with traders divided on whether the move signals long-term pricing power or risks subscriber losses to competitors. While some investors view the pullback as a buying opportunity given the company's strong fundamentals, others are expressing frustration over technical weakness and the stock's failure to maintain momentum.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending as traders debate its potential for a short squeeze amid high short interest and a recent technical "golden cross." While bulls are optimistic about the stock's discounted valuation relative to AI sector growth, bears and skeptics remain focused on concerns regarding management, past accounting scrutiny, and volatility linked to option expirations.

Asana, Inc. engages in the business of developing a work management platform that helps organizations orchestrate work from daily tasks to cross-functional strategic initiatives. The company was founded by Dustin Moskovitz and Justin Michael Rosenstein on December 16, 2008 and is headquartered in San Francisco, CA.

Asana Inc - Ordinary Shares - Class A

Asana Inc

Asana shares are trending lower following a quarterly earnings report where the company's fiscal outlook fell short of some investor expectations. While there is debate regarding the company's long-term potential as an AI-driven work management platform, the current sentiment is dominated by disappointment over the third-quarter results and guidance.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath shares experienced high volatility following a fiscal second-quarter report that featured a revenue and earnings beat alongside raised annual guidance, sparking intense debate between traders over valuation concerns and the pace of growth in its agentic AI products. While many investors view the pullback as a buying opportunity, others remain cautious, pointing to high short interest and questions regarding the company's long-term momentum.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly's shares are receiving attention following a significant second-quarter earnings beat, driven by strong growth in its Mounjaro and Zepbound franchises, and a subsequent upward revision of its full-year revenue guidance. While the community is debating potential long-term price targets, sentiment remains largely bullish, with traders highlighting the company's expanding obesity drug market and pipeline prospects.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

The community is primarily focused on expectations for significant company updates and product shipments throughout September, often citing anticipated industry events like CIOE as catalysts for potential commercial news. While some traders are bullish on the company's production scale-up and institutional positioning, others express skepticism and frustration regarding the lack of immediate revenue and previous communication challenges.

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Twist Bioscience Corp

The community is currently discussing the recent approval of a $17.05 million investor settlement, which resolves allegations that the company misled shareholders regarding its manufacturing processes and profitability between 2018 and 2022. Traders are actively sharing information on eligibility criteria and the claim submission process for those impacted by past share price declines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the two following September healthcare conferences in New York City: Morgan Stanley 24th Annual Global Healthcare Conference on Mon., Sept. 14, from 11:30 a.m.-12:05 p.m. EDT Baird 2026...

NeuroPace Faces an IGE Delay: What the FDA Setback Means for Growth

NPCE's IGE expansion faces a regulatory delay, shifting focus to rising RNS adoption as the company works through the FDA review process.

Is NeuroPace a Buy as Growth Improves but Valuation Stays Elevated?

NPCE's stronger RNS adoption, narrowing losses and AI expansion support growth, but premium valuation, liquidity and regulatory risks warrant patience.

NPCE Is Down 12.7% in 3 Months: Is the Pullback a Buying Opportunity?

NeuroPace's stronger RNS growth, raised 2026 guidance and AI expansion face a less certain IGE regulatory path after the FDA setback.

Ahmet Tezel Executes Sell Order: Offloads $876K In LivaNova Stock

A substantial insider sell was reported on August 13, by Ahmet Tezel, Chief Innovation Officer at LivaNova (NASDAQ:LIVN), based on the recent SEC filing.
What Happened: Tezel's recent Form 4 filing with the U.S.read more...

LivaNova (LIVN) Q2 2026 Earnings Call Transcript

LivaNova (LIVN) Q2 2026 Earnings Call Transcript...

LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised

LIVN's Q2 earnings and revenues beat estimates as Cardiopulmonary and Epilepsy growth fuels margin gains and a raised 2026 outlook.

INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease

Inspire Medical raised its 2026 outlook after a Q2 beat, as Inspire V mix and cost control offset weak U.S. procedure activity.

LivaNova (LIVN) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for LivaNova (LIVN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

LivaNova PLC (LIVN) Hits Fresh High: Is There Still Room to Run?

LivaNova (LIVN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

• Reported GAAP EPS of $1.98 up 296.00% YoY
• Reported revenue of $390.6M up 10.81% YoY
• LivaNova now expects full-year 2026 revenue to grow between 8% and 9% on a constant-currency basis and adjusted diluted earnings per share in the range of $4.30 to $4.40.

LivaNova lowered its full-year 2026 adjusted free cash flow guidance, experienced a decline in quarterly GAAP operating income, and faces various structural risks including supply chain and regulatory uncertainties.

LivaNova raised its full-year 2026 financial guidance, secured a long-term supply agreement for critical oxygenator components, and reported positive clinical data for its PolySync programming algorithm in sleep apnea treatment.

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

LivaNova PLC

Bearish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Current Price	$82.09
Prev Close	$81.20
Open	$81.40
Dividend Yield	0.00%
50-Day Moving Average	$80.67
Beta	0.95
Avg. Volume	717,070.05
PE Ratio	24.09

52-Week High	$85.76
52-Week Low	$48.82
Market Capitalization	$4.47B
EPS (Annual)	-$4.45
Price to Book	3.37
Revenue Per Employee	$420,622.12

Feed

News

Sentiment

Earnings

Fundamentals

Info

LIVN Fundamentals